Skip to main content
. 2016 Jan 10;2016:1501527. doi: 10.1155/2016/1501527

Figure 1.

Figure 1

The frequency of entry to the inner area in an elevated open space with a novel object (for anxiety status) of different experimental groups of rats. acAD versus control/sham operated rats at day 14 (p < 0.01), bcAD versus control/sham operated rats at day 21 (p < 0.001), ccAD versus etoricoxib treated cAD at all the doses at day 14 (p < 0.001), and dcAD versus etoricoxib treated cAD at all the doses at day 21 (p < 0.001). AD: intracerebroventricular colchicine injected Alzheimer Disease rats, AD + E (10): AD rats treated with 10 mg/kg body weight of etoricoxib, AD + E (20): AD rats treated with 20 mg/kg body weight of etoricoxib, and AD + E (30): AD rats treated with 30 mg/kg body weight of etoricoxib. Values are expressed in mean ± SEM (n = 6 in each group).